Odyssey Therapeutics, Inc.
ODTX
$20.73
$0.010.05%
NASDAQ
| 06/30/2026 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Net Income | -37.96% | -7.29% | |||
| Total Depreciation and Amortization | -10.93% | -2.46% | |||
| Total Amortization of Deferred Charges | -- | -- | |||
| Total Other Non-Cash Items | 394.86% | -13.53% | |||
| Change in Net Operating Assets | 116.33% | 145.84% | |||
| Cash from Operations | 15.91% | 11.29% | |||
| Capital Expenditure | -25.68% | 96.87% | |||
| Sale of Property, Plant, and Equipment | -- | 55.56% | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -705.26% | -33.57% | |||
| Cash from Investing | -707.56% | -31.71% | |||
| Total Debt Issued | -- | -- | |||
| Total Debt Repaid | -91.67% | 0.00% | |||
| Issuance of Common Stock | 44,763.75% | -97.45% | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | 200.00% | -- | |||
| Cash from Financing | 60,263.64% | 59,261.50% | |||
| Foreign Exchange rate Adjustments | 333.33% | 368.12% | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | 908.94% | 2,658.34% | |||